Transformed B-cell Lymphoma Unclassifiable with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Transformed B-cell Lymphoma Unclassifiable with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating epcoritamab in combination with dose-adjusted EPOCH-R for aggressive B-cell non-Hodgkin lymphoma;…